Parkinson's Disease, Macular Degeneration and Cutaneous Signs of Mercury Toxicity
Overview
Authors
Affiliations
Objective: The objective of this study was to determined if there was a relationship between Grover's disease and Parkinson disease.
Methods: Fourteen patients with Parkinson disease and 14 control patients were randomly selected and examined for cutaneous eruptions and blood mercury levels.
Results: Of the 14 patients with Parkinson's disease, 13 had Grover's disease and detectable blood mercury. None of the patients in the control group had a cutaneous eruption and only 2of the 14 had detectable blood mercury.
Conclusion: Mercury may play a role in the etiology of Parkinson disease and Grover's disease.
Mercury and Parkinson's Disease: Promising Leads, but Research Is Needed.
Torrey E, Simmons W Parkinsons Dis. 2023; 2023:4709322.
PMID: 37744289 PMC: 10517869. DOI: 10.1155/2023/4709322.
Serum zinc deficiency could be associated with dementia conversion in Parkinson's disease.
Lee J, Park S, Jang W Front Aging Neurosci. 2023; 15:1132907.
PMID: 37181629 PMC: 10172503. DOI: 10.3389/fnagi.2023.1132907.
Zebrafish as a Potential Model for Neurodegenerative Diseases: A Focus on Toxic Metals Implications.
Paduraru E, Iacob D, Rarinca V, Plavan G, Ureche D, Jijie R Int J Mol Sci. 2023; 24(4).
PMID: 36834835 PMC: 9959844. DOI: 10.3390/ijms24043428.
Pyatha S, Kim H, Lee D, Kim K Antioxidants (Basel). 2022; 11(12).
PMID: 36552676 PMC: 9774122. DOI: 10.3390/antiox11122467.
The Role of Xenobiotics and Trace Metals in Parkinson's Disease.
Bjorklund G, Dadar M, Chirumbolo S, Aaseth J Mol Neurobiol. 2019; 57(3):1405-1417.
PMID: 31754997 DOI: 10.1007/s12035-019-01832-1.